Skip to main content
Top
Published in: Inflammation 4/2008

01-08-2008

Neonates with Culture Proven Sepsis Have Lower Amounts and Percentage of CD45RA+ T Cells

Authors: A. Denizmen Aygun, A. Nese Citak Kurt, Ahmet Godekmerdan, Abdullah Kurt, Saadet Akarsu, M. Kaya Gurgoze, Erdal Yilmaz

Published in: Inflammation | Issue 4/2008

Login to get access

Abstract

To evaluate the expression of lymphocyte subsets in newborns diagnosed as culture proven or culture negative sepsis and to investigate the differentiation. The aim of this study is to explore neonatal immunology in newborns diagnosed as culture proven or culture negative neonatal sepsis and to identify their place in the diagnosis. This prospective study was performed in newborns who were diagnosed as neonatal sepsis and hospitalized in a tertiary care hospital and who were classified as culture proven sepsis (n = 12), as culture negative sepsis (n = 21) and healthy (n = 17). Lymphocyte subsets were obtained at time of diagnosis. Culture proven sepsis had statistically significant increase of WBC compared to culture negative sepsis and control groups (p < 0.05). Significant decreases were observed of percentage of lymphocyte, when compared to culture negative sepsis and control group (p < 0.05). Percentage of CD4+ was lower in culture proven sepsis and absolute count of CD4+ was lower in culture negative sepsis (p < 0.05). Percentage and absolute count of CD45RA+ were lower in culture negative sepsis than control and percentage of CD45RA+ was lower in culture proven sepsis than control (p < 0.05). Percentage of CD45RO+ was higher in culture proven sepsis than control group (p < 0.05). It is clear that during neonatal sepsis lymphocyte subsets are different from healthy controls. Whether the described abnormalities represent the absence of a normal maturation process, rather, pathological events is still not clear.
Literature
1.
go back to reference Hodge, G., S. Hodge, P. Han, and R. Halsam. 2004. Multiple leucocyte activation markers to detect neonatal infection. Clin. Exp. Immunol. 135:125–129.PubMedCrossRef Hodge, G., S. Hodge, P. Han, and R. Halsam. 2004. Multiple leucocyte activation markers to detect neonatal infection. Clin. Exp. Immunol. 135:125–129.PubMedCrossRef
2.
go back to reference Juretic, E., A. Juretic, B. Uzaravic, and M. Petrovecki. 2001. Alterations in lymphocyte phenotype of infected preterm newborns. Biol. Neonate. 80:223–227.PubMedCrossRef Juretic, E., A. Juretic, B. Uzaravic, and M. Petrovecki. 2001. Alterations in lymphocyte phenotype of infected preterm newborns. Biol. Neonate. 80:223–227.PubMedCrossRef
3.
go back to reference Weinschenk, N. P., A. Farina, and D. W. Bianchi. 2000. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J. Pediatr. 137:345–350.PubMedCrossRef Weinschenk, N. P., A. Farina, and D. W. Bianchi. 2000. Premature infants respond to early-onset and late-onset sepsis with leukocyte activation. J. Pediatr. 137:345–350.PubMedCrossRef
4.
go back to reference Hodge, S., G. Hodge, R. Flower, and P. Han. 1998. Surface activation markers of T lymphocytes: role in the detection of infection in neonates. Clin. Exp. Immunol. 113:33–38.PubMedCrossRef Hodge, S., G. Hodge, R. Flower, and P. Han. 1998. Surface activation markers of T lymphocytes: role in the detection of infection in neonates. Clin. Exp. Immunol. 113:33–38.PubMedCrossRef
5.
go back to reference Philip, A. G., and J. R. Hewitt. 1980. Early diagnosis of neonatal sepsis. Pediatrics 65:1036–1041.PubMed Philip, A. G., and J. R. Hewitt. 1980. Early diagnosis of neonatal sepsis. Pediatrics 65:1036–1041.PubMed
6.
go back to reference Holub, M., Z. Kluckova, B. Benada, J. Hobstova, I. Huzicka, J. Prazak, and A. Lobovska. 2000. Changes in lymphocyte subpopulations and CD3+/DR+ expression in sepsis. Clin. Microbiol. Infect. 6:657–660.PubMedCrossRef Holub, M., Z. Kluckova, B. Benada, J. Hobstova, I. Huzicka, J. Prazak, and A. Lobovska. 2000. Changes in lymphocyte subpopulations and CD3+/DR+ expression in sepsis. Clin. Microbiol. Infect. 6:657–660.PubMedCrossRef
7.
go back to reference Blackwell, T. S., and J. W. Christman. 1996. Sepsis and cytokines: current status. Br. J. Anaesth. 77:110–117.PubMed Blackwell, T. S., and J. W. Christman. 1996. Sepsis and cytokines: current status. Br. J. Anaesth. 77:110–117.PubMed
8.
go back to reference Pietsch, J. B., J. L. Meakins, and L. D. MacLean. 1977. The delayed hypersensitivity response: application to clinical surgery. Surgery 82:349–355.PubMed Pietsch, J. B., J. L. Meakins, and L. D. MacLean. 1977. The delayed hypersensitivity response: application to clinical surgery. Surgery 82:349–355.PubMed
9.
go back to reference Cheadle, W. G., R. M. Pemberton, D. Robinson, D. H. Livingston, J. L. Rodriguez, and H. C. Polk. 1993. Lymphocyte subset responses to trauma and sepsis. J. Trauma 35:844–849.PubMedCrossRef Cheadle, W. G., R. M. Pemberton, D. Robinson, D. H. Livingston, J. L. Rodriguez, and H. C. Polk. 1993. Lymphocyte subset responses to trauma and sepsis. J. Trauma 35:844–849.PubMedCrossRef
10.
go back to reference Fantin, B., V. Joly, C. Elbim, J. L. Golmard, M. A. Gougerot-Pocidalo, P. Yeni, and C. Carbon. 1996. Lymphocyte subset counts during the course of community-acquired pneumonia: evolution according to age, human immunodeficiency virus status, and etiologic microorganisms. Clin. Infect. Dis. 22:1096–1098.PubMed Fantin, B., V. Joly, C. Elbim, J. L. Golmard, M. A. Gougerot-Pocidalo, P. Yeni, and C. Carbon. 1996. Lymphocyte subset counts during the course of community-acquired pneumonia: evolution according to age, human immunodeficiency virus status, and etiologic microorganisms. Clin. Infect. Dis. 22:1096–1098.PubMed
11.
go back to reference Godula-Stuglik, U., B. Mazur, G. Mikusz, T. Torbus, and L. Tomanek. 1999. Lymphocyte subpopulations in full-term septic neonates. Pediatr. Int. 41:500–505.PubMedCrossRef Godula-Stuglik, U., B. Mazur, G. Mikusz, T. Torbus, and L. Tomanek. 1999. Lymphocyte subpopulations in full-term septic neonates. Pediatr. Int. 41:500–505.PubMedCrossRef
12.
go back to reference Sofatzis, P., P. Mexi Bourna, G. Liossis, I. Driva, S. Alexia, and C. Costales. 1996. Lymphocyte subpopulations in neonatal sepsis. Perinatal Neonatal Med. 1:215. Sofatzis, P., P. Mexi Bourna, G. Liossis, I. Driva, S. Alexia, and C. Costales. 1996. Lymphocyte subpopulations in neonatal sepsis. Perinatal Neonatal Med. 1:215.
13.
go back to reference Commans-Bitter, W. M., R. de Groot, R. van den Beemd et al. 1997. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulation. J. Pediatr. 130:388–393.CrossRef Commans-Bitter, W. M., R. de Groot, R. van den Beemd et al. 1997. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulation. J. Pediatr. 130:388–393.CrossRef
14.
go back to reference Ballow, M., K. L. Cates, J. C. Rowe, C. Goetz, and A. G. Pantschenko. 1987. Peripheral blood T-cell subpopulations in the very low birth weight (less than 1500 g) infants. Am. J. Hematol. 24:85–92.PubMedCrossRef Ballow, M., K. L. Cates, J. C. Rowe, C. Goetz, and A. G. Pantschenko. 1987. Peripheral blood T-cell subpopulations in the very low birth weight (less than 1500 g) infants. Am. J. Hematol. 24:85–92.PubMedCrossRef
15.
go back to reference Adkins, B., C. Leclerc, and S. M. Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553–564.PubMedCrossRef Adkins, B., C. Leclerc, and S. M. Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4:553–564.PubMedCrossRef
16.
go back to reference Ikinciogullari, A., T. Kendirli, F. Dogu, Y. Egin, I. Reisli, S. Cin, and E. Babacan. 2004. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk. J. Pediatr. 46:125–130.PubMed Ikinciogullari, A., T. Kendirli, F. Dogu, Y. Egin, I. Reisli, S. Cin, and E. Babacan. 2004. Peripheral blood lymphocyte subsets in healthy Turkish children. Turk. J. Pediatr. 46:125–130.PubMed
17.
go back to reference Clement, L. T., P. E. Vink, and G. E. Bradley. 1990. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J. Immunol. 145:102–108.PubMed Clement, L. T., P. E. Vink, and G. E. Bradley. 1990. Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate. J. Immunol. 145:102–108.PubMed
18.
go back to reference Wallace, D. L., and P. C. Beyerely. 1990. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 69:460–467.PubMed Wallace, D. L., and P. C. Beyerely. 1990. Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells. Immunology 69:460–467.PubMed
19.
go back to reference Yamada, A., T. Kaneyuki, A. Hara, D. M. Rothstein, and M. M. Yokoyama. 1992. CD45 isoform expression on human neonatal T cells: expression and turnover of CD45 isoforms on neonatal versus adult T cells after activation. Cell Immunol. 142:114–124.PubMedCrossRef Yamada, A., T. Kaneyuki, A. Hara, D. M. Rothstein, and M. M. Yokoyama. 1992. CD45 isoform expression on human neonatal T cells: expression and turnover of CD45 isoforms on neonatal versus adult T cells after activation. Cell Immunol. 142:114–124.PubMedCrossRef
20.
go back to reference Johannison, A., and R. Festin. 1995. Phenotype transition of CD4+ T cells from CD45RA+ to CD45RO+ is accompanied by cell activation and proliferation. Cytometry 19:343–353.CrossRef Johannison, A., and R. Festin. 1995. Phenotype transition of CD4+ T cells from CD45RA+ to CD45RO+ is accompanied by cell activation and proliferation. Cytometry 19:343–353.CrossRef
21.
go back to reference Michie, C., and D. Harvey. 1994. Can expression of CD45RO, a T-cell surface molecule, be used to detect congenital infection. Lancet 343:1259–1260.PubMedCrossRef Michie, C., and D. Harvey. 1994. Can expression of CD45RO, a T-cell surface molecule, be used to detect congenital infection. Lancet 343:1259–1260.PubMedCrossRef
Metadata
Title
Neonates with Culture Proven Sepsis Have Lower Amounts and Percentage of CD45RA+ T Cells
Authors
A. Denizmen Aygun
A. Nese Citak Kurt
Ahmet Godekmerdan
Abdullah Kurt
Saadet Akarsu
M. Kaya Gurgoze
Erdal Yilmaz
Publication date
01-08-2008
Publisher
Springer US
Published in
Inflammation / Issue 4/2008
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-008-9068-0

Other articles of this Issue 4/2008

Inflammation 4/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.